Hannah A DeBerg

13PUBLICATIONS
80CO-AUTHORS
AutoimmunityMedical mycologyEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 04, 2026
The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity.

|Jun 05, 2026
Type I Interferon-Driven Monocyte Dysregulation and MAS-associated CD8+ T cells During Macrophage Activation Syndrome.

|Dec 22, 2025
The altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity.

Victoria Volfson-Sedletsky, Hannah A DeBerg, Mitch L Fahning

|Sep 18, 2025
Genetic and epigenetic screens in primary human T cells link candidate causal autoimmune variants to T cell networks.

Ching-Huang Ho, Maxwell A Dippel, Meghan S McQuade

|Aug 12, 2024
T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.

Hannah A DeBerg, Mitch L Fahning, Suraj R Varkhande

|Dec 19, 2023
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy.

Astrid L Voskamp, Sugandhika Khosa, Tracy Phan

Pageof 3

Frequent Collaborators

3 joint publications

Cate Speake

3 joint publications

Daniel J Campbell

3 joint publications

Martin Prlic

3 joint publications

Erik Wambre